Impact News +++ First Phosphate Corp.: First Phosphate Announces Uplisting of American Depositary Receipt (ADR) to Nasdaq... (Newsfile) +++ FIRST PHOSPHATE Aktie +4,02%

Gewinn & Umsatz News zur WUXI APPTEC Aktie

>WUXI APPTEC Aktienkurs

21.485 EUR +9.8% (TradegateBSX)

Ask: 21.695 EUR / 233 Stück

Bid: 21.35 EUR / 237 Stück

Tagesumsatz: 804 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

WUXI APPTEC Aktie über LYNX handeln

Intraday

1 Jahr

>WUXI APPTEC Performance

1 Woche: +21,3%

1 Monat: +29,7%

3 Monate: +40,9%

6 Monate: +71,9%

1 Jahr: +95,3%

laufendes Jahr: +100,8%

>WUXI APPTEC Aktie

Profil:

WuXi AppTec Co., Ltd. is a leading global pharmaceutical and biotechnology company that provides comprehensive research and development services. Its primary function is to facilitate drug discovery and development processes for pharmaceutical compan..
>Volltext..

Insiderhandel:

>WUXI APPTEC Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>WUXI APPTEC Peer Group

Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten

>WUXI APPTEC Chart & Kurs - Tradegate

>WUXI APPTEC Gewinn & Umsatz News

04.08.26 - 07:03	WuXi AppTec extends rally to nearly five-year high after H1 earnings beat (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

04.08.26 - 06:36	Jefferies′ Cui Cui on Wuxi Apptec′s Earnings (Bloomberg)
	Jefferies Head of Asia Healthcare Research says the outlook for Wuxi Apptec remains bright. She spoke with "Bloomberg: The China Show" after Wuxi Apptec reported an earnings beat and raised its full year guidance. (Source: Bloomberg)...

03.08.26 - 14:30

Chinese biotech giant Wuxi AppTec sees first-half earnings surge amid US scrutiny (SCMP)

Wuxi AppTec, Asia's largest provider of contract pharmaceutical research, posted net income that smashed market expectations in the first half of the year amid strong demand tied to weight-loss and diabetes drugs, as well as gains in its US business. Interim net profit attributable to the owners of the Shanghai-based drug contractor advanced 33.7 per cent to 11.08 billion yuan (US$1.64 billion) from a year earlier, surpassing a Bloomberg mean consensus estimate – drawn from a pool of 25 analysts......

28.04.26 - 11:30

WuXi AppTec shares surge 14% in Hong Kong after record first-quarter earnings (SCMP)

Shares of WuXi AppTec surged both on the mainland and in Hong Kong after stronger-than-expected quarterly results lifted sentiment across the contract research and innovative drug sectors. The pharmaceutical company's Shanghai-listed shares rose by their daily limit of 10 per cent to close at 110.57 yuan on Tuesday, while its Hong Kong shares ended 14 per cent higher at HK$143.10, the highest since December 2021. The gains followed the company's market-beating first-quarter earnings released......

28.04.26 - 07:31	WuXi AppTec surges on strong Q1 earnings; chemistry unit drives growth (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.04.26 - 13:30

WuXi AppTec posts record first-quarter revenue on strong global demand (SCMP)

China's drug maker WuXi AppTec reported record first-quarter revenue, as a robust order backlog and sustained demand from global pharmaceutical companies supported growth. For the three months ended March 31, the Shanghai- and Hong Kong-listed company posted revenue of 12.44 billion yuan (US$1.72 billion), up 28.81 per cent year on year, according to a filing released on Monday. Net profit climbed nearly 27 per cent to 4.65 billion yuan in the quarter. Both revenue and net profit exceeded market......

24.03.26 - 06:30	WuXi AppTec shares rally as FY profit more than doubles (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

13.01.26 - 05:30	WuXi AppTec shares surge on upbeat 2025 profit outlook (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

28.07.25 - 11:54	WuXi AppTec Half-Year Revenue Beats Despite Tariff Threat (Bloomberg)
	WuXi AppTec Co. reported first-half revenue that beat expectations, overcoming challenges brought on by trade tariffs and US-China tensions....

11.07.25 - 02:42	Wuxi AppTec sees strong profit growth for 1H25 (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was sein wird - wird sein. - Sprichwort Indien

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram